Renhe Pharmacy Co

Renhe Pharmacy Co Financial Leverage

The Financial Leverage (Equity Multiplier) of Renhe Pharmacy Co (000650.SZ) as of Oct 16, 2026 is 1.22. In the previous year, Financial Leverage (Equity Multiplier) was 1.21 — a change of 1.05% (higher).

Financial Leverage

1.22

YoY

1.05%

Last updated:

Financial Leverage (Equity Multiplier) of Renhe Pharmacy Co is 2025 1.22 . Financial Leverage (Equity Multiplier) of Renhe Pharmacy Co was 2024 1.21 . It decreases by 1.05% higher compared to the previous year.

The Renhe Pharmacy Co Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.36 CNY
Jan 1, 2019
1.31 CNY
Jan 1, 2020
1.24 CNY
Jan 1, 2021
1.31 CNY
Jan 1, 2022
1.33 CNY
Jan 1, 2023
1.24 CNY
Jan 1, 2024
1.21 CNY
Jan 1, 2025
1.22 CNY
The Renhe Pharmacy Co Financial Leverage history
YEARFinancial LeverageYoY
1.22+1.05%
1.21-2.43%
1.24-6.56%
1.33+1.75%
1.31+5.12%
1.24-5.11%
1.31-3.78%
1.36-1.73%
1.39-1.37%
1.40+6.31%
1.32+3.42%
1.28—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Renhe Pharmacy Co Stock analysis

What does Renhe Pharmacy Co do? Renhe Pharmacy Co Ltd is a pharmaceutical company based in Nanchang, China, operating within the Health Care sector. The company, listed on the Shenzhen Stock Exchange under ticker 000650.SZ, has been publicly traded since its IPO on December 10, 1996. Renhe Pharmacy employs 6,062 full-time staff and focuses on the manufacturing and distribution of pharmaceutical products. Its product portfolio includes various dosage forms such as capsules, granules, tablets, powders, injections, suppositories, and ointments. The company operates primarily within China, distributing its products domestically. Renhe Pharmacy is engaged in both the industrial manufacturing of pharmaceuticals and the retail and wholesale distribution of health-related products. The firm's headquarters are located in Nanchang, Jiangxi Province, and it maintains a website at https://www.renheyaoye.com/photography, though the content of the site is not detailed here. The company's activities are centered around the production and sale of pharmaceuticals, with no indication of international operations or significant acquisitions beyond the information provided. The business model emphasizes domestic market presence, serving both medical institutions and consumers through its product range. Renhe Pharmacy Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Renhe Pharmacy Co stock

Financial Leverage (Equity Multiplier) of Renhe Pharmacy Co is 1.22 in 2025.

Financial Leverage (Equity Multiplier) of Renhe Pharmacy Co changed from 1.21 to 1.22, representing a 1.05% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Renhe Pharmacy Co since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Renhe Pharmacy Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Renhe Pharmacy Co

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Renhe Pharmacy Co